BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10536426)

  • 1. [Proposal for an informed consent form for hormonal replacement therapy in ambulatory care].
    Capri O; Perrone G; Cecchi R; Palazzetti PL; Zichella L; Merli S
    Minerva Ginecol; 1999; 51(7-8):303-7. PubMed ID: 10536426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause].
    Perrone G; Capri O; Borrello M; Galoppi P
    Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The menopause, hormone replacement therapy and informed consent: are women in an underresourced country adequately aware?
    Maharaj NR; Gangaram R; Moodley J
    J Obstet Gynaecol; 2007 Apr; 27(3):300-4. PubMed ID: 17464817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A physiopathological overview of climacteric and menopause].
    Aranda Gallegos JE; Barrón Vallejo J; Ortega Díaz R; Pereyra Quiñones R; Kably Ambe A
    Ginecol Obstet Mex; 1998 Jun; 66():253-8. PubMed ID: 9679402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies in HRT.
    Teede HJ
    Aust Fam Physician; 2002 May; 31(5):413-8. PubMed ID: 12043543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy in postmenopausal women: utilization of health care resources by new users.
    Thorp JM; Gavin NI; Ohsfeldt RL
    Am J Obstet Gynecol; 2001 Aug; 185(2):318-26. PubMed ID: 11518885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopause medicine: current treatment options and trends.
    Birkenfeld A; Kase NG
    Compr Ther; 1991 Jul; 17(7):36-45. PubMed ID: 1742968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal hormone replacement therapy and major clinical outcomes: a focus on cardiovascular disease, osteoporosis, dementia, and breast and endometrial neoplasia.
    Dick SE; DeWitt DE; Anawalt BD
    Am J Manag Care; 2002 Jan; 8(1):95-104; quiz 105-6. PubMed ID: 11814176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hormonal replacement therapy on skin biophysical properties of menopausal women.
    Guinot C; Malvy D; Ambroisine L; Latreille J; Mauger E; Guéhenneux S; Morizot F; Tschachler E
    Skin Res Technol; 2005 Aug; 11(3):201-4. PubMed ID: 15998332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Justification for the use of HRT in the long-term prevention of osteoporosis.
    Stevenson JC
    Maturitas; 2005 Jun; 51(2):113-26. PubMed ID: 15917151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of physicians' advice and recommendations on the compliance with hormone replacement therapy in the treatment of postmenopausal symptoms in Japanese women--a prospective study.
    Ushiroyama T; Ikeda A; Sakuma K; Ueki M
    J Med; 2004; 35(1-6):163-9. PubMed ID: 18084874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
    J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Historical perspective of hormone replacement therapy].
    Chanson P
    Rev Prat; 2005 Feb; 55(4):369-75. PubMed ID: 15828614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.